Ad
related to: AbbVie
Search results
Canandaigua National Bank & Trust Co. Trims Holdings in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 2 days agoCanandaigua National Bank & Trust Co. reduced its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 3.1% in the 1st quarter, according to the company in its most ...
Ahead of CEO transition, AbbVie names new lead board director
Crain s Chicago Business· 11 hours agoAustin, 63, is president of Austin Investment Advisors, a private investment and consulting firm. Previously, she was president and CEO of internet television services company Move Networks ...
Walden Wealth Partners LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoWalden Wealth Partners LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) during the fourth quarter, according to the company in its most recent Form 13F ...
1,533 Shares in AbbVie Inc. (NYSE:ABBV) Acquired by Warren Street Wealth Advisors LLC
ETF DAILY NEWS· 3 days agoWarren Street Wealth Advisors LLC acquired a new position in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent 13F filing with the ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Vanguard Group Inc.
ETF DAILY NEWS· 3 days agoVanguard Group Inc. trimmed its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.2% during the 4th quarter, according to its most recent filing with the Securities and ...
AbbVie (ABBV) Exceeds Market Returns: Some Facts to Consider
Zacks· 3 days agoFree Report) ending at $171.36, denoting a +0.99% adjustment from its last day's close. This change outpaced the S&P 500's 0.25% gain on the day. In that same time, the Medical sector gained ...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks via Yahoo Finance· 7 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop...
Optimist Retirement Group LLC Purchases New Shares in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 7 days agoOptimist Retirement Group LLC acquired a new stake in AbbVie Inc. (NYSE:ABBV – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities ...
AbbVie’s SKYRIZI gains US FDA approval for ulcerative colitis
Pharmaceutical Technology via Yahoo Finance· 2 days agoAbbVie has announced receipt of US Food and Drug Administration (FDA) approval for SKYRIZI...
Raleigh Capital Management Inc. Has $2.67 Million Position in AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 5 days agoRaleigh Capital Management Inc. grew its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 3.9% during the 4th quarter, according to the company in its most recent disclosure ...
